2F-Ketamine Pellets – 100mg for sale
Our 2F-Ketamine Pellets are meticulously formulated research chemicals designed for laboratory use. Each pellet contains 100mg of 2-Fluoroketamine, a synthetic compound known for its dissociative and anesthetic properties. These pellets are carefully synthesized to ensure purity and consistency in research experiments. Please note that 2F-Ketamine Pellets are strictly intended for scientific research purposes and should not be consumed or used for any other non-scientific applications.
Product Attributes:
- Chemical Name: 2-Fluoroketamine
- CAS Number: N/A
- Molecular Formula: C13H16FNO
- Form: Pellets
- Purity: High purity research-grade compound
- Dosage per Pellet: 100mg
Usage Instructions:
2F-Ketamine Pellets are exclusively intended for research purposes in controlled laboratory environments. Trained professionals should handle these pellets, following proper safety protocols and utilizing appropriate protective equipment, such as gloves and goggles. Researchers may choose to further analyze the pellets or administer them to subjects as part of their scientific investigations.
Safety Data:
- This product is solely for research purposes and should not be ingested or used for any other purposes.
- Contact with skin or eyes may cause irritation. In case of contact, rinse thoroughly with water and seek medical attention if irritation persists.
- Avoid direct inhalation and ensure usage in well-ventilated areas.
- Keep out of reach of children and pets.
- Store in a cool, dry place away from heat and direct sunlight.
Packaging and Shipping Information:
Our 2F-Ketamine Pellets are carefully packaged to maintain their quality during shipping. We provide various shipping options tailored to meet your specific requirements. Please note that shipping is available within Canada only. It is important to emphasize that compliance with all applicable laws and regulations regarding the purchase and use of research chemicals is the sole responsibility of the buyer.
Reviews
There are no reviews yet.